Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
Silvercorp to Acquire Adventus Creating a Diversified Mining Company (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Breaking & Recent News Perrigo Company plc PRGO

Healthcare
Perrigo Company plc is an Ireland-based provider of over the counter (OTC) health and wellness solutions that are designed to enhance individual well-being. The Company's segments include Consumer Self-Care Americas (CSCA) and Consumer Self-Care International (CSCI). The CSCA segment comprises its consumer self-care business (OTC, infant formula, and oral care categories, and contract... see more

Recent & Breaking News (NYSE:PRGO)

Perrigo Receives Binding Offer to Divest its HRA Pharma Rare Diseases Business for up to €275 Million

PR Newswire 1 day ago

Perrigo to Release First Quarter 2024 Financial Results on May 7, 2024

PR Newswire 3 days ago

Opill and WNBA Team Up for Groundbreaking Partnership

PR Newswire April 9, 2024

Perrigo Commences Shipments of Opill® to Retailers Nationwide, Empowering Millions to Enter a New Era of Reproductive Health Access in the United States

PR Newswire March 4, 2024

Perrigo to Attend UBS Global Consumer and Retail Conference

PR Newswire February 29, 2024

Perrigo Reports Fourth Quarter & Fiscal Year 2023 Financial Results From Continuing Operations; Launches Investment & Efficiency Program

PR Newswire February 27, 2024

Perrigo Increases its Quarterly Dividend

PR Newswire February 26, 2024

Perrigo to Release Fourth Quarter and Fiscal Year 2023 Financial Results on February 27, 2024

PR Newswire February 13, 2024

Perrigo Announces Early Results of Cash Tender Offer for Notes

PR Newswire November 29, 2023

Perrigo Announces Cash Tender Offer for Notes

PR Newswire November 10, 2023

Perrigo Reports Third Quarter Fiscal Year 2023 Financial Results From Continuing Operations

PR Newswire November 7, 2023

Perrigo Announces Quarterly Dividend

PR Newswire November 2, 2023

Perrigo to Attend Upcoming Consumer Investor Conferences

PR Newswire October 31, 2023

Perrigo to Release Third Quarter 2023 Financial Results on November 7, 2023

PR Newswire October 24, 2023

Perrigo Announces Leadership Update

PR Newswire September 11, 2023

Perrigo to Attend Upcoming Consumer Investor Conferences

PR Newswire August 24, 2023

Perrigo Reports Second Quarter Fiscal Year 2023 Financial Results From Continuing Operations

PR Newswire August 8, 2023

PERRIGO ANNOUNCES QUARTERLY DIVIDEND

PR Newswire August 2, 2023

Perrigo to Release Second Quarter 2023 Financial Results and Present at an Industry Growth Conference

PR Newswire July 25, 2023

Perrigo Announces U.S. FDA Approval for Opill® OTC Daily Oral Contraceptive

PR Newswire July 13, 2023